# Biomarin Pharmaceutical Inc: Form 8-K, filed Oct 6, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 16:22 ET
- Period: 2026-10-06
- Accession: 0001048477-26-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000104847726000019/bmrn-20261006.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000104847726000019/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000104847726000019/bmrn-20261006.htm

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001048477-26-000019. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.